Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Ethanol and Methylphenidate

supplement:

Ethanol

Research Papers that Mention the Interaction

Ethanol elevates methylphenidate (1) plasma concentrations and yields the metabolite ethylphenidate (2).
Journal of medicinal chemistry  •  2005  |  View Paper
Background/Purpose Ethanol coadministered with immediate-release dl-methylphenidate ( dl-MPH ) or dexmethylphenidate (d-MPH) significantly increases the geomean maximum plasma concentration (Cmax) of d-MPH 22% and 15%, respectively, and elevates overall drug exposure and psychostimulant effects.
Findings/Results Ethanol increased the second pulse of d-MPH Cmax for dl-MPH by 35% (P < 0.01) and the partial area under the plasma concentration curve from 4 to 8 hours by 25% (P < 0.05).
Implications/Conclusions These findings support drug dispositional interactions between ethanol and MPH as dominant over potential biopharmaceutical considerations.
Journal of clinical psychopharmacology  •  2017  |  View Paper
Interestingly it is also produced as a metabolite from the co-ingestion of methylphenidate and alcohol (ethanol).
Forensic science international  •  2015  |  View Paper
A pharmacokinetic interaction between the l-isomer of dl-MPH and ethanol has previously been shown to increase early exposure to d-MPH.
The dl-MPH– ethanol combination significantly (P < 0.05) increased these AUCs with the exception of like (P = 0.08).
Journal of clinical psychopharmacology  •  2015  |  View Paper
This study explores the … that: (1) ethanol will interact with dl‐Methylphenidate (MPH) to enantioselectively elevate plasma d‐MPH, and primarily yield l‐ethylphenidate as a transesterification metabolite; (2) women will exhibit lower relative bioavailability of MPH than men; and (3) sex‐dependent differences in subjective effects will exist.
Clinical pharmacology and therapeutics  •  2007  |  View Paper
Chi‐squared tests revealed that when alcohol was used in combination with any of cannabis, psilocybin, MDMA, cocaine, amphetamine, methylphenidate (ps < 0.01) or LSD (p < 0.05) its initial use preceded the administration of the other substance.
Paired samples t‐tests revealed that when alcohol was used with cocaine (p < 0.01) or methylphenidate (p < 0.05) it was ingested in greater quantities than when used in their absence.
Human psychopharmacology  •  2006  |  View Paper
Nonetheless, given the high likelihood that methylphenidate and ethanol coingestion frequently occurs, the detection of ethylphenidate in humans warrants further investigation into the extent of its formation as well as into any associated toxicity in nonoverdose situations.
Journal of clinical psychopharmacology  •  1999  |  View Paper
MPD also counteracted the effect of ethanol on the amplitude of P2 and N3.
Rearings were eliminated by ethanol in the open field but increased by MPD, and MPD counteracted the effect of ethanol on rearings.
Some of these results might help explain why users take MPD and ethanol in combination in order to enable consuming larger amounts of alcohol.
Alcohol  •  2019  |  View Paper
By understanding how the combination of methylphenidate and alcohol affects memory, we can better assess the risks of taking both substances simultaneously.
Pharmacology Biochemistry and Behavior  •  2016  |  View Paper
Recent epidemiological studies report the co‐abuse of MPH and ethanol in adolescents and young adults.
The European journal of neuroscience  •  2014  |  View Paper
Show More